Aaron Bartlone
Fortune : 156 161 $ au 31/05/2026
Fortune : 156 161 $ au 31/05/2026
Aaron Bartlone currently works at Cybin, Inc., as Chief Operating Officer from 2023.
Mr. Bartlone also formerly worked at Ab Dynamix LLC, as President & Managing Director, Eli Lilly & Co., as Various Director from 1997 to 2006, and UCB, Inc., as Chief Quality, Patient Safety, HSE & Risk Officer.
Mr. Bartlone received his graduate degree from the University of Notre Dame and undergraduate degree from Youngstown State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CYBIN, INC. 0,07 % | 27/05/2026 | 34 321 ( 0,07 % ) | 156 161 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CYBIN INC. | Directeur des opérations | 01/07/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2006 |
Ab Dynamix LLC | Directeur Général | - |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | President | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Youngstown State University
Youngstown State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Cybin, Inc.
Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Ab Dynamix LLC |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national